SUTRO BIOPHARMA INC (STRO) Stock Analyst Earnings Estimates
NASDAQ:STRO - Nasdaq - US8693671021 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 61.88M 44.85% | 67.77M 9.52% | 153.731M 126.84% | 60.184M -60.85% | 55.163M -8.34% | 51.418M -6.79% | 144.14M 180.33% | 241.82M 67.77% | 372.52M 54.05% | 601.34M 61.42% | 627.15M 4.29% | 735.34M 17.25% | |
| EBITDA YoY % growth | -93.68M -40.32% | -123.25M -31.56% | -82.462M 33.09% | -232.433M -181.87% | -283.932M -22.16% | -354.96M -25.02% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -98.52M -38.64% | -128.94M -30.88% | -89.278M 30.76% | -243.031M -172.22% | -298.9M -22.99% | -324.551M -8.58% | -246.057M 24.19% | -170.34M 30.77% | -35.876M 78.94% | 149.8M 517.55% | 259.16M 73.00% | 368.24M 42.09% | |
| Operating Margin | -159.21% | -190.26% | -58.07% | -403.81% | -541.85% | -631.20% | -170.71% | -70.44% | -9.63% | 24.91% | 41.32% | 50.08% | |
| EPS YoY % growth | -2.29 6.91% | -2.44 -6.55% | -1.78 27.05% | -2.96 -66.09% | -3.10 -4.88% | -2.93 5.49% | -2.64 9.85% | -2.12 19.69% | -1.41 33.65% | -0.17 87.68% | 1.70 1,082.35% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.85 -263.02% | -0.87 8.38% | -0.84 -42.92% | -0.79 -33.98% | -0.90 -6.29% | -0.68 21.72% | -0.64 24.52% | -0.64 18.71% | -0.62 31.28% |
| Revenue Q2Q % growth | 12.685M -88.85% | 9.18M -29.43% | 9.214M -64.16% | 9.249M 8.56% | 7.582M -40.23% | N/A | N/A | 1.658M -82.07% | 9.187M 21.17% |
| EBITDA Q2Q % growth | -59.747M -219.57% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -65.75M -252.37% | -69.741M -23.24% | -72.532M -48.98% | -74.24M -9.31% | -85.271M -29.69% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.59 27.16% | -0.75 | 0.16 | 21.27% |
| Q2 2024 Q2Q % growth | -0.59 7.81% | -0.81 | 0.22 | 26.97% |
| Q1 2024 Q2Q % growth | -0.95 -11.76% | -0.94 | -0.01 | -1.02% |
| Q4 2023 Q2Q % growth | 0.52 176.47% | -0.84 | 1.36 | 161.92% |
| Q3 2023 Q2Q % growth | -0.81 -118.92% | -0.75 | -0.06 | -7.90% |
| Q2 2023 Q2Q % growth | -0.64 -16.36% | -0.75 | 0.11 | 14.34% |
| Q1 2023 Q2Q % growth | -0.85 -1.19% | -0.83 | -0.02 | -2.70% |
| Q4 2022 Q2Q % growth | -0.68 18.07% | -0.63 | -0.05 | -7.31% |
| Q3 2022 Q2Q % growth | -0.37 44.78% | -0.75 | 0.38 | 50.87% |
| Q2 2022 Q2Q % growth | -0.55 -323.08% | -0.47 | -0.08 | -16.86% |
| Q1 2022 Q2Q % growth | -0.84 -27.27% | -0.77 | -0.07 | -8.72% |
| Q4 2021 Q2Q % growth | -0.83 43.92% | -0.70 | -0.13 | -18.15% |
| Q3 2021 Q2Q % growth | -0.67 -248.89% | -0.66 | -0.01 | -0.86% |
| Q2 2021 Q2Q % growth | -0.13 77.97% | -0.42 | 0.29 | 69.20% |
| Q1 2021 Q2Q % growth | -0.66 21.43% | -0.62 | -0.04 | -7.28% |
| Q4 2020 Q2Q % growth | -1.48 -131.25% | -0.58 | -0.90 | -154.56% |
| Q3 2020 Q2Q % growth | 0.45 180.36% | -0.52 | 0.97 | 186.99% |
| Q2 2020 Q2Q % growth | -0.59 1.67% | -0.66 | 0.07 | 10.15% |
| Q1 2020 Q2Q % growth | -0.84 -35.48% | -0.70 | -0.14 | -19.60% |
| Q4 2019 Q2Q % growth | -0.64 | -0.71 | 0.07 | 9.56% |
| Q3 2019 Q2Q % growth | -0.56 | -0.67 | 0.11 | 16.09% |
| Q2 2019 Q2Q % growth | -0.60 | -0.69 | 0.09 | 13.18% |
| Q1 2019 Q2Q % growth | -0.62 | -0.65 | 0.03 | 4.28% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 8.52M -49.66% | 15.558M | -7.038M | -45.24% |
| Q2 2024 Q2Q % growth | 25.706M 146.89% | 21.441M | 4.265M | 19.89% |
| Q1 2024 Q2Q % growth | 13.008M 2.64% | 12.312M | 696K | 5.65% |
| Q4 2023 Q2Q % growth | 113.721M 1,217.74% | 12.044M | 101.677M | 844.21% |
| Q3 2023 Q2Q % growth | 16.924M -32.71% | 13.259M | 3.665M | 27.64% |
| Q2 2023 Q2Q % growth | 10.412M -62.95% | 12.808M | -2.396M | -18.71% |
| Q1 2023 Q2Q % growth | 12.674M 114.81% | 11.373M | 1.301M | 11.44% |
| Q4 2022 Q2Q % growth | 8.63M -18.97% | 14.768M | -6.138M | -41.56% |
| Q3 2022 Q2Q % growth | 25.15M 195.19% | 12.932M | 12.218M | 94.48% |
| Q2 2022 Q2Q % growth | 28.1M 0.18% | 17.021M | 11.079M | 65.09% |
| Q1 2022 Q2Q % growth | 5.9M -59.75% | 10.675M | -4.775M | -44.73% |
| Q4 2021 Q2Q % growth | 10.65M 28.62% | 10.865M | -215K | -1.98% |
| Q3 2021 Q2Q % growth | 8.52M -52.19% | 9.148M | -628K | -6.86% |
| Q2 2021 Q2Q % growth | 28.05M 196.20% | 13.605M | 14.445M | 106.17% |
| Q1 2021 Q2Q % growth | 14.66M 105.03% | 5.843M | 8.817M | 150.90% |
| Q4 2020 Q2Q % growth | 8.28M -26.79% | 9.575M | -1.295M | -13.52% |
| Q3 2020 Q2Q % growth | 17.82M 45.11% | 8.67M | 9.15M | 105.54% |
| Q2 2020 Q2Q % growth | 9.47M -10.07% | 8.128M | 1.342M | 16.51% |
| Q1 2020 Q2Q % growth | 7.15M -17.15% | 10.909M | -3.759M | -34.46% |
| Q4 2019 Q2Q % growth | 11.31M | 10.158M | 1.152M | 11.34% |
| Q3 2019 Q2Q % growth | 12.28M | 10.062M | 2.218M | 22.04% |
| Q2 2019 Q2Q % growth | 10.53M | 8.555M | 1.975M | 23.09% |
| Q1 2019 Q2Q % growth | 8.63M | 9.022M | -392K | -4.34% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 11.02% | 0% | 1.92% |
| Revenue | -0.24% | 11.57% | 0% | -10.68% |